Skip to main content

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Investor Notice: Lawsuit Alleges Securities Laws Violations

San Diego, CA -- (SBWIRE) -- 06/22/2021 -- An investor, who purchased NASDAQ:ACRX shares, filed a lawsuit over alleged violations of Federal Securities Laws by AcelRx Pharmaceuticals, Inc.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.